Bright CD38 expression is an indicator of MYC rearrangement

Leukemia and Lymphoma

Volumn 50, Issue 6, 2009, Pages 1054-1057

  Maleki, Atousa ^a   Seegmiller, Adam C ^a   Uddin, Naseem ^a   Karandikar, Nitin J ^a   Chen, Weina ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; CD38 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HERMES ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; KI 67 ANTIGEN; MYC PROTEIN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CHILD; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DUPLICATION; GENE REARRANGEMENT; HUMAN; IMMUNOPHENOTYPING; MALE; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD38; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-MYC; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 68449101742     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190902930470     Document Type: Article

References (8)

1. Diebold J, Jeffe ES, Raphael M, Warnke RA. Burkitt lymphoma In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumors of Haematopoieitc and Lymphoid Tissues. Lyon, France: IARC Press; 2001. pp 181-184.
2. Cogliatti SB, Novak U, Henz S, Schmid U, Moller P, Barth TF. Diagnosis of Burkitt lymphoma in due time: A practical approach. Br J Haematol 2006;134:294-301.
3. Haralambieva E, Boerma EJ, van Imhoff GW, Rosati S, Schuuring E, Muller-Hermelink HK, et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol 2005;29:1086-1094.
4. McClure RF, Remstein ED, Macon WR, Dewald GW, Habermann TM, Hoering A, et al. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. Am J Surg Pathol 2005;29:1652-1660.
5. Rodig SJ, Vergilio JA, Shahsafaei A, Dorfman DM. Characteristic Expression Patterns of TCL1, CD38, and CD44 Identify Aggressive Lymphomas Harboring aMYC Translocation. Am J Surg Pathol 2008;32:113-122.
6. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-3849.
7. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma, EJ, et al.Molecular diagnosis of Burkitt's lymphoma. N Engl JMed 2006;354:2431-2442.
8. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006;354:2419-2430.